Work

Dual inhibition of DNA double strand break (DSB) repair and PI3K pathway with BEZ235 (BEZ) to sensitize refractory metastatic (met) triple negative breast cancer (TNBC) to nab paclitaxel/cisplatin (pac/cis) in a patient with an exceptional response (ExRx).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.28_suppl.156

Authors: Joyce O'Shaughnessy, Virginia A. Espina, Irene Cherni, John D. Carpten, Lance A. Liotta, David W. Craig, Jeff Kiefer, Nicholas N Hoke, Maren K. Levin, Kai Wang, Corinne Ramos

Institutions: George Mason University, Translational Genomics Research Institute, Baylor University Medical Center, Foundation Medicine (United States)

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590534344

Cites:

Cited by: 13

Related to: 10